Using Risk-Based Thinking to Strengthen Combined & Companion QMS for Medical Devices & Combination Products in Your QMS



Using Risk-Based Thinking to Strengthen Combined & Companion QMS for Medical Devices & Combination Products in Your QMS

Published on 05/12/2025

Using Risk-Based Thinking to Strengthen Combined & Companion QMS for Medical Devices & Combination Products in Your QMS

Introduction to Combined & Companion QMS

The integration of a combined and companion Quality Management System (QMS) for medical devices and combination products is essential for ensuring compliance with regulatory requirements set forth by authorities such as the FDA, EMA, and MHRA. This article serves as a step-by-step tutorial for quality managers, regulatory affairs, and compliance professionals to implement a robust QMS that leverages risk-based thinking.

In regulated industries, the importance of a well-structured QMS cannot be

overstated. It not only ensures compliance with Good Manufacturing Practices (GMP) but also enhances product quality and patient safety. This tutorial will guide you through the phases of developing and strengthening your combined and companion QMS, focusing on objectives, documentation, roles, and inspection expectations.

Step 1: Understanding Regulatory Frameworks

The first step in developing a combined and companion QMS is to understand the regulatory frameworks that govern medical devices and combination products. In the US, the FDA provides guidelines that must be adhered to, while in the EU, the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) set the standards.

In this phase, it is crucial to familiarize yourself with the following:

  • FDA Regulations: Understand the relevant sections of the Code of Federal Regulations (CFR), particularly 21 CFR Part 820 for Quality System Regulation (QSR).
  • ISO Standards: ISO 13485:2016 outlines requirements for a QMS specific to medical devices.
  • EMA and MHRA Guidelines: Review the guidelines provided by the European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA) for compliance in the UK and EU.

Documentation required in this phase includes regulatory guidelines, internal compliance checklists, and training materials for staff. The roles involved typically include regulatory affairs specialists, quality managers, and compliance officers. Inspection expectations will focus on the understanding and application of these regulations during audits.

Step 2: Risk Management Planning

Risk management is a critical component of a combined and companion QMS. The objective of this step is to identify, assess, and control risks associated with medical devices and combination products. This aligns with ISO 14971, which provides a framework for risk management in medical devices.

See also  How to Implement Combined & Companion QMS for Medical Devices & Combination Products in FDA-, EMA- and MHRA-Regulated Environments

Key activities in this phase include:

  • Risk Identification: Conduct brainstorming sessions and use tools such as Failure Mode and Effects Analysis (FMEA) to identify potential risks.
  • Risk Assessment: Evaluate the identified risks based on their severity and likelihood of occurrence.
  • Risk Control: Develop strategies to mitigate identified risks, including design changes, additional testing, or enhanced labeling.

Documentation should include a risk management plan, risk assessment reports, and risk control measures. Roles in this phase typically involve risk management teams, quality assurance personnel, and product development teams. Inspection expectations will focus on the thoroughness of risk assessments and the effectiveness of risk control measures.

Step 3: Developing Quality Policies and Objectives

Once risks have been identified and managed, the next step is to develop quality policies and objectives that align with the overall business strategy. The objective here is to establish a clear framework for quality expectations within the organization.

In this phase, consider the following:

  • Quality Policy: Develop a quality policy that reflects the organization’s commitment to quality and compliance.
  • Quality Objectives: Set measurable quality objectives that align with regulatory requirements and organizational goals.
  • Communication: Ensure that quality policies and objectives are communicated effectively throughout the organization.

Documentation should include the quality policy statement, quality objectives, and communication plans. Roles involved typically include senior management, quality managers, and department heads. Inspection expectations will focus on the visibility and understanding of quality policies among employees.

Step 4: Implementing Document Control Systems

Document control is a vital aspect of a combined and companion QMS. The objective of this step is to ensure that all documents related to quality management are properly managed, maintained, and accessible. This is crucial for compliance with both FDA and ISO requirements.

Key activities in this phase include:

  • Document Creation: Develop standard operating procedures (SOPs), work instructions, and forms that are necessary for quality management.
  • Document Review and Approval: Establish a process for reviewing and approving documents before they are released.
  • Document Distribution: Ensure that all relevant personnel have access to the most current versions of documents.

Documentation should include a document control procedure, a master document list, and records of document reviews and approvals. Roles typically involve document control specialists, quality managers, and department heads. Inspection expectations will focus on the effectiveness of the document control system and the accessibility of documents during audits.

Step 5: Training and Competence Development

Training and competence development are essential for ensuring that employees understand their roles within the QMS and are equipped to perform their tasks effectively. The objective of this step is to establish a comprehensive training program that meets regulatory requirements and enhances employee competence.

See also  Aligning Integration of QMS Software with LIMS, MES, ERP & CRM Systems with Data Integrity and ALCOA++ Principles

In this phase, consider the following:

  • Training Needs Assessment: Identify the training needs of employees based on their roles and responsibilities.
  • Training Program Development: Develop a training program that includes both initial and ongoing training for employees.
  • Training Records: Maintain records of all training activities, including attendance and competency assessments.

Documentation should include a training plan, training materials, and training records. Roles involved typically include training coordinators, quality managers, and department heads. Inspection expectations will focus on the adequacy of training programs and the competency of employees during audits.

Step 6: Monitoring and Measurement of Processes

Monitoring and measurement are critical for assessing the effectiveness of the QMS. The objective of this step is to establish processes for monitoring key performance indicators (KPIs) and measuring the effectiveness of the QMS.

Key activities in this phase include:

  • Establishing KPIs: Identify and define KPIs that are relevant to quality management and regulatory compliance.
  • Data Collection: Implement processes for collecting data related to KPIs.
  • Data Analysis: Analyze data to identify trends, areas for improvement, and compliance with quality objectives.

Documentation should include a monitoring and measurement plan, KPI definitions, and data analysis reports. Roles typically involve quality managers, data analysts, and department heads. Inspection expectations will focus on the effectiveness of monitoring processes and the use of data for decision-making.

Step 7: Internal Audits and Management Reviews

Internal audits and management reviews are essential for evaluating the effectiveness of the QMS and ensuring continuous improvement. The objective of this step is to establish a systematic approach to conducting internal audits and management reviews.

In this phase, consider the following:

  • Internal Audit Planning: Develop an internal audit schedule that covers all aspects of the QMS.
  • Conducting Audits: Perform internal audits to assess compliance with QMS procedures and regulatory requirements.
  • Management Reviews: Conduct management reviews to evaluate the performance of the QMS and identify opportunities for improvement.

Documentation should include internal audit reports, management review meeting minutes, and action plans for addressing non-conformities. Roles involved typically include internal auditors, quality managers, and senior management. Inspection expectations will focus on the thoroughness of audits and the effectiveness of management reviews in driving improvements.

Step 8: Continuous Improvement

The final step in strengthening your combined and companion QMS is to establish a culture of continuous improvement. The objective of this step is to foster an environment where employees are encouraged to identify areas for improvement and implement changes that enhance quality and compliance.

Key activities in this phase include:

  • Feedback Mechanisms: Implement mechanisms for employees to provide feedback on processes and suggest improvements.
  • Corrective and Preventive Actions (CAPA): Establish a CAPA process to address non-conformities and prevent recurrence.
  • Training on Continuous Improvement: Provide training to employees on continuous improvement methodologies such as Lean and Six Sigma.
See also  Product & Design Quality Management Software Templates, Examples and Documentation Requirements

Documentation should include a continuous improvement plan, CAPA records, and training materials. Roles typically involve quality managers, process improvement teams, and department heads. Inspection expectations will focus on the effectiveness of continuous improvement initiatives and the organization’s commitment to quality.

Conclusion

Implementing a combined and companion QMS for medical devices and combination products requires a systematic approach that incorporates risk-based thinking. By following the steps outlined in this tutorial, quality managers, regulatory affairs, and compliance professionals can develop a robust QMS that meets regulatory requirements and enhances product quality.

As you embark on this journey, remember that the key to success lies in understanding regulatory frameworks, managing risks effectively, and fostering a culture of continuous improvement. By doing so, your organization will not only achieve compliance but also contribute to the safety and well-being of patients worldwide.